What factors drove the changes in Mettler-Toledo's revenue and profit?

What does Mettler-Toledo do and what are its main business segments?

What were the key takeaways from Mettler-Toledo's earnings call?

What is Mettler-Toledo's latest dividend and current dividend yield?

What is the revenue and EPS growth rate for Mettler-Toledo year over year?

What guidance did Mettler-Toledo's management provide for the next earnings period?

What were the key takeaways from Mettler-Toledo’s earnings call?

What is Mettler-Toledo's gross profit margin?

- **Q4 2025 Strong Finish**: $1.1B revenue, 5% local currency growth, $13.36 EPS (8% YoY). Product Inspection (+11%), Industrial (+7%), and Food Retail (+19%) led growth.
- **2026 Guidance**: 4% sales growth, 8-9% EPS growth. Cautious Q1 (+3% sales, +5-7% EPS) but optimistic on long-term automation/digitalization trends.
- **Key Risks**: Tariffs (2025 EPS -5%), macro uncertainty, but Swiss tax rate cut provided $0.95 EPS benefit.
- **Strategic Wins**: Service business hits $1B, emerging markets (18% of sales) growing above average, and China biopharma expansion.

**【CEO Summary Section】**
- Reported Q4 2025 revenue of $1.1 billion, with local currency growth of 5% (4% excluding acquisitions). Adjusted EPS was $13.36, up 8% YoY. 
- Highlighted strong performance in Product Inspection (+11% Q4), Industrial (+7%), and Food Retail (+19%).
- 2026 guidance: Local currency sales growth of 4% (3.5% excluding acquisitions), adjusted EPS of $46.05-$46.75 (8-9% growth). 
- Emphasized cautious start to 2026 due to macro uncertainty, but optimistic on long-term trends in automation, digitalization, and onshoring.

**【CFO Financial Commentary】**
- Q4 2025 financials: 
  - Gross margin 59.8% (-140bps vs prior year, 190bps tariff impact)
  - Operating margin 32.1% (-160bps vs prior year)
  - Free cash flow $878M (99% of adjusted net income)
- 2026 outlook: 
  - Operating margin to improve 60-70bps (excluding FX)
  - Free cash flow ~$900M
  - Share buybacks $825M-$875M
- Tariffs estimated to reduce 2025 EPS by 5%, but Swiss tax rate cut provided $0.95 EPS benefit.

**【Q&A Highlights】**
- **Q1 2026 Guidance**: Local currency sales +3%, adjusted EPS $8.60-$8.75 (5-7% growth). Cautious due to macro uncertainty, but expect gradual improvement.
- **China Strategy**: 3% Q4 growth driven by biopharma. Long-term opportunity from pharmacopeia compliance and pharma onshoring.
- **Service Business**: Reached $1B in annual sales. Mid-single-digit growth expected, targeting $3B addressable market.
- **Tariff Impact**: 2025 operating profit reduced by $50M, but 2026 outlook assumes tariffs remain at current levels.
- **Emerging Markets**: 18% of sales, growing above company average. Focus on dedicated resources and digital capabilities.


Mettler-Toledo International Inc. (MTD) Q4 2025 Earnings Call Transcript

- **Q3 Revenue Beat**: $1.03B (+8% YoY), driven by 9% Industrial and 4% Lab growth.
- **EPS Strength**: $11.15 (+9%), despite 7% tariff headwind.
- **2026 Guidance**: 4% sales growth, $45.35-$46 EPS, with tariffs fully offset.
- **Strategic Wins**: China Industrial growth resumes, onshoring investments, and 8% service segment expansion.

**【CEO Summary Section】**
- **Strong Q3 Results**: Revenue of $1.03 billion (+8% YoY), driven by 9% growth in Industrial and 4% in Laboratory. Adjusted EPS was $11.15 (+9%).
- **Strategic Initiatives**: Success of Spinnaker sales program, investments in automation/digitalization, and onshoring trends. China's Industrial business grew for the first time in 2 years.
- **2026 Outlook**: Guided for 4% sales growth, with cautious macro assumptions but optimism on replacement demand and near-shoring.

**【CFO Financial Commentary】**
- **Q3 Financials**: Gross margin 59.2% (-80bps due to tariffs). Adjusted operating profit $309.9M (+5%), free cash flow $689.5M.
- **Q4 Guidance**: Sales +3%, EPS $12.68-$12.88 (7% tariff headwind). 2026 EPS $45.35-$46 (+8-9%), with tariffs fully offset.
- **Acquisitions**: $75M in 2025, adding 1%+ sales and modest EPS accretion.

**【Q&A Highlights】**
- **Segment Growth**: Lab (+4%), Industrial (+9%), Product Inspection (+7%). 2026 core Industrial and Product Inspection expected low-mid single digits.
- **China Dynamics**: Low single-digit growth in Lab and Industrial, benefiting from Pharmacopoeia updates.
- **Tariff Mitigation**: 6% headwind offset via pricing, supply chain, and innovation.
- **Service Segment**: 8% growth, targeting mid-single-digit expansion in 2026.

Mettler-Toledo International Inc. (MTD) Q3 2025 Earnings Call Transcript

- **EPS Guidance Downgrade**: Full-year EPS reduced by $0.40 to $41.70-$42.20 due to 39% U.S. tariffs on Swiss imports.
- **Industrial Strength**: Core industrial +2%, product inspection +8%, driven by automation and new product launches.
- **Tariff Mitigation**: 2026 costs to be fully offset via pricing (+3.5% H2) and supply chain changes.
- **Growth Drivers**: Onshoring (40% of revenue in life sciences), equipment replacement, and digitalization.

**【CEO Summary Section】**
- Reported Q2 revenue of $983 million, with local currency growth of 2% and U.S. dollar growth of 4%. Adjusted EPS was $10.09, up 5% year-over-year.
- Tariffs on Swiss imports increased to 39%, reducing full-year EPS guidance by $0.40 to $41.70-$42.20. Mitigation efforts aim to fully offset costs in 2026.
- Strong performance in Industrial (core automation +2%, product inspection +8%) and Lab (bioprocessing growth offsetting academic softness). Service business grew 4% in Q2 and 5% year-to-date.
- Onshoring and equipment replacement are key growth drivers, with 40% of revenue tied to life sciences and 50% supporting production processes.

**【CFO Financial Commentary】**
- Gross margin was 59.0%, down 70bps due to tariffs and lower volume. Operating margin contracted 120bps to 28.8%, with tariffs contributing a 130bps headwind.
- Q3 guidance: local currency sales +3-4%, adjusted EPS $10.55-$10.75 (+3-5%). Full-year sales growth 1-2% (excluding 1.5% drag from 2023 shipping delays).
- Free cash flow expected at $860 million, with $875 million in share buybacks.

**【Q&A Highlights】**
- **Tariff Mitigation**: Pricing (+3% Q2, targeting 3.5% for H2) and supply chain optimization will offset $95M annualized tariff costs. 2026 mitigation fully offset.
- **China**: Flat Q2 sales, no stimulus assumed in forecast. Focus on e-mobility, GLP-1, and pharmacopeia compliance.
- **Product Inspection**: Mid-single-digit growth driven by new mid-range portfolio. Q3 guidance for core industrial and product inspection is mid- to high-single-digit.
- **Replacement Cycle**: 80-90% of West business pre-COVID was replacement; aging installed base and onshoring will drive future growth.
- **Onshoring**: Biopharma manufacturing in the U.S. will benefit from QA/QC and production equipment sales.

Mettler-Toledo International Inc. (MTD) Q2 2025 Earnings Call Transcript

- **Q1 Growth Resilience:** Local currency sales +3% excluding delays, driven by Lab innovation and Product Inspection expansion.
- **Tariff Mitigation Success:** 75%+ of $115M annual tariff costs offset via supply chain, pricing, and surcharges.
- **China Caution:** Q2 sales down low-mid single digits; full year expects flat to low single-digit growth in Lab, Industrial decline.
- **Service Growth Engine:** 6% Q1 service revenue growth, targeting mid-single digits annually with 35% sales from consumables.
- **Onshoring Upside:** Sensors and QC tools poised to benefit from U.S. reshoring trends in biopharma and manufacturing.

**【CEO Summary Section】**
- Q1 2025 revenue was $884M, down 3% in local currency, driven by delayed shipments recovery in Q1 2024. Excluding this, local currency sales grew 3%.
- Lab business showed strong growth, with Process Analytics benefiting from biopharma trends and digital sensor innovations.
- Industrial segment growth was led by Product Inspection (+8%), offset by Core Industrial decline (-6%).
- Gross margin improved 30bps to 59.5%, driven by price realization and SternDrive program efficiency.
- Tariffs cost $115M annually, with mitigation actions expected to fully offset by 2026.

**【CFO Financial Commentary】**
- Adjusted EPS was $8.19, down 8% YoY, with a 18% headwind from delayed shipments recovery.
- Operating margin was 26.8%, down 210bps YoY, but expanded 50bps excluding prior year distortions.
- Free cash flow was $180M, impacted by $36M in bonus payments.
- 2025 guidance: Local currency sales growth 1-2%, adjusted EPS $41.25-$42, with a 2% net tariff headwind.

**【Business Unit Updates】**
- **Lab:** New balances, titrators, and thermal analysis instruments drove growth. Process Analytics saw strong biopharma adoption.
- **Industrial:** Product Inspection growth offset Core Industrial softness; food retail declined 12%.
- **Geographic Performance:** Americas (+3%), Europe (+4%), China flat. China tariffs caused $115M annualized headwind.

**【Q&A Highlights】**
- **China Outlook:** Q2 sales down low-mid single digits; full year flat to low single-digit growth in Lab, down low single-digit in Industrial.
- **Tariff Mitigation:** 75%+ of costs offset via supply chain shifts (e.g., Mexico manufacturing), pricing (+3%), and surcharges.
- **Onshoring Opportunity:** Long-term upside from U.S. reshoring, with sensors and QC tools positioned for new factories.
- **Service Growth:** 6% Q1 growth, targeting mid-high single digits annually; 35% of sales from service and consumables.
- **Tariff Impact Timing:** Q2 gross margin headwind of 6%, net 3% after mitigation; full year net 2% EPS headwind.

Mettler-Toledo International Inc. (MTD) Q1 2025 Earnings Conference Call Transcript

- **Q4 2024 Strong Finish**: $1.045B revenue (+12% YoY), $12.41 EPS (+32%), 100%+ cash flow conversion.
- **2025 Growth Drivers**: Automation, service expansion, and SternDrive 3.0 productivity.
- **Lab Dominance**: Europe pharma/biopharma up 10%+, X-ray inspection mid-market share gains.
- **China Caution**: 2025 growth 1%-2%, no stimulus benefits baked in.
- **Margin Expansion**: Gross margin 61.2% (+220bps), operating margin 33.7% (+360bps).

**【CEO Opening Remarks】**
- Q4 2024 revenue of $1.045B (+12% YoY, +7% local currency), driven by 18% growth in Laboratory products and 12% in Product Inspection.
- Adjusted EPS of $12.41 (+32% YoY), with strong cash flow of $900.6M and 100%+ of adjusted net income.
- 2025 priorities: automation/digitalization, service growth, and operational excellence through SternDrive 3.0.

**【CFO Financial Breakdown】**
- **Sales by Region**: Europe +19% LC, Americas +7%, Asia/ROW +14% (China +4%).
- **Product Lines**: Lab +18%, Industrial +8% (Core +5%, Inspection +12%), Food Retail -14%.
- **Margins**: Gross margin 61.2% (+220bps), Operating margin 33.7% (+360bps), driven by volume, pricing, and productivity.
- **2025 Guidance**: Local currency sales +3% (excluding delays), adjusted EPS $42.35-$43 (+3%-5%).

**【CEO Business Updates】**
- **Lab Strength**: Europe pharma/biopharma demand, 10%+ growth ex-shipping delays.
- **Industrial Momentum**: X-ray inspection tech gains mid-market share, offsetting weak China industrial.
- **Geographic Highlights**: Europe +8% LC, Asia/ROW +10% (Japan/India growth), China modest +2%.
- **Service Growth**: +8% Q4, targeting mid-single-digit 2025 expansion.

**【Q&A Key Themes】**
- **China Risks**: Low single-digit 2025 growth expected, cautious on stimulus impact.
- **Tariff Mitigation**: Pricing and supply chain flexibility, <10% revenue exposed to Mexico tariffs.
- **Lab Recovery**: Biopharma spending improving, but small biotech still weak.
- **Industrial Outlook**: Core +low single-digit, Inspection +mid-single-digit, Food Retail cautious.


Mettler-Toledo International Inc. (MTD) Q4 2024 Earnings Call Transcript

Mettler-Toledo International (MTD)-8 Nov 24-2024 Q3 Earnings call transcript

Mettler-Toledo International (MTD)-2 Aug 24-2024 Q2 Earnings call transcript

Mettler-Toledo International (MTD)-10 May 24-2024 Q1 Earnings call transcript

Mettler-Toledo International (MTD)-9 Feb 24-2023 Q4 Earnings call transcript

Mettler-Toledo International (MTD)-10 Nov 23-2023 Q3 Earnings call transcript

Mettler-Toledo International (MTD)-27 Jul 23-2023 Q2 Earnings call transcript

Mettler-Toledo International (MTD)-5 May 23-2023 Q1 Earnings call transcript

Mettler-Toledo International (MTD)-3 Nov 22-2022 Q3 Earnings call transcript

Mettler-Toledo International (MTD)-30 Jul 22-2022 Q2 Earnings call transcript

Mettler-Toledo International (MTD)-6 May 22-2022 Q1 Earnings call transcript

Mettler-Toledo International (MTD)-11 Feb 22-2021 Q4 Earnings call transcript

Mettler-Toledo International (MTD)-5 Nov 21-2021 Q3 Earnings call transcript

Mettler-Toledo International (MTD)-30 Jul 21-2021 Q2 Earnings call transcript

Mettler-Toledo International (MTD)-9 May 21-2021 Q1 Earnings call transcript

Mettler-Toledo International (MTD)-5 Feb 21-2020 Q4 Earnings call transcript

Mettler-Toledo International (MTD)-8 Nov 20-2020 Q3 Earnings call transcript

Mettler-Toledo International (MTD)-1 Aug 20-2020 Q2 Earnings call transcript

Mettler-Toledo International (MTD)-10 May 20-2020 Q1 Earnings call transcript

Mettler-Toledo International (MTD)-6 Feb 20-2019 Q4 Earnings call transcript

Mettler-Toledo International (MTD)-8 Nov 19-2019 Q3 Earnings call transcript

Mettler-Toledo International (MTD)-2 Aug 19-2019 Q2 Earnings call transcript

Mettler-Toledo International (MTD)-10 May 19-2019 Q1 Earnings call transcript

Mettler-Toledo International (MTD)-7 Feb 19-2018 Q4 Earnings call transcript

Mettler-Toledo International (MTD)-11 Nov 18-2018 Q3 Earnings call transcript

Mettler-Toledo International (MTD)-27 Jul 18-2018 Q2 Earnings call transcript

Mettler-Toledo International (MTD)-4 May 18-2018 Q1 Earnings call transcript

Mettler-Toledo International (MTD)-8 Feb 18-2017 Q4 Earnings call transcript

Mettler-Toledo International (MTD)-3 Nov 17-2017 Q3 Earnings call transcript

Actual															4	5.29	7.02	9.26	6.56	8.1	8.72	10.53	7.87	9.39	10.18	12.1	8.69	10.19	9.8	9.4	8.89	9.65	10.21	12.41	8.19	10.09	11.15	13.36
Forecast															3.8912	4.213	5.9857	8.7188	5.6141	7.6176	8.2797	10.0991	7.2845	8.7673	9.8355	11.6769	8.6079	9.9849	9.719	10.1028	7.6449	9.0324	10.0131	11.7229	7.8821	9.5974	10.658	12.8018
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+2.80%	+25.56%	+17.28%	+6.21%	+16.85%	+6.33%	+5.32%	+4.27%	+8.04%	+7.10%	+3.50%	+3.62%	+0.95%	+2.05%	+0.83%	-6.96%	+16.29%	+6.84%	+1.97%	+5.86%	+3.91%	+5.13%	+4.62%	+4.36%

MTD

MTD fundamentals

MTD Q4 2025 Earnings

Earnings Call

You can ask Aime

MTD

MTD fundamentals

MTD Q4 2025 Earnings

Earnings Call

MTD Earnings Call Summary for Q4/20258:30 AM on Feb 6, 2026

MTD Earnings Call Summary for Q3/20258:30 AM on Nov 7, 2025

MTD Earnings Call Summary for Q2/20258:30 AM on Aug 1, 2025

MTD Earnings Call Summary for Q1/20258:30 AM on May 2, 2025

MTD Earnings Call Summary for Q4/20248:30 AM on Feb 7, 2025

You can ask Aime